Well we have a poster presentation of Ph2 Interim data happening in very early June at ASCO 2021:
Link to the abstract & conference:
https://meetinglibrary.asco.org/record/199691/abstract
https://conferences.asco.org/am/program?cmpid=js_ascoorg_am_register_psrh_googleadwords_ascobrand_042921_060321___program-sitelink&gclid=EAIaIQobChMI8ueIsuDh8AIV0BxyCh1SiwVFEAAYASABEgKJrfD_BwE
The abstract is a brief summary of what will be presented at the conference. We are already aware that this interim review by the IDMC is what stopped the trial early on positive results & further recruitment. Data up until interim review will be presented.
https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02365535-3A565607?access_token=83ff96335c2d45a094df02a206a39ff4
Since then, in April, a statistical trigger has occurred in PFS (progression free survival), so now we await further results in Her-Vaxx Ph2 in what has been a very lengthy trial (in a positive way) for survival of late stage gastric cancer patients, as LC discussed in the webinar recently.
GLTAH
Why IMU is a multi multi bagger, page-1924
-
- There are more pages in this discussion • 24,194 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
-0.003(5.08%) |
Mkt cap ! $416.4M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 5.9¢ | 5.5¢ | $2.898M | 51.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 4186955 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 337877 | 2 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |